Coronary Morphology and Conduction System Disturbance Induced by Therapeutic Embolization of the Coronary Septal Artery


  • Otoni M. Gomes
  • Antônio Alves Coelho
  • Evandro César Vidal Osterne
  • Rafael Diniz Abrantes



Background: Percutaneous transluminal septal myocardial alcohol ablation (PTSMAA) is not a procedure without complications. It may produce heart arrhythmias, especially those due to disturbances of atrioventricular (AV) and interventricular (IV) electrical conduction.

Objective: The goal of this study was to evaluate the relationship between the anatomical patterns of the right coronary artery and the left anterior descending artery (LAD) and to relate them to the AV and IV bundle branch blocks provoked by PTSMAA.

Method: Twenty patients with obstructive hypertrophic cardiomyopathy resistant to treatment with drugs successfully underwent PTSMAA. Electrocardiographic analyses were done before and after PTSMAA, and the results were compared with the abnormal septal anatomy.

Results: The effectiveness of PTSMAA was obtained in 18 (90%) of the 20 patients by ethanolization of the first great septal branch. In the other 2 patients (10%), 2 septal branches underwent alcoholization. First-grade temporary AV block (AVB) was observed in 6 patients (30%). Ten patients experienced severe bradycardia due to total AVB that required a temporary pacemaker, but 3 of the patients (15%) required a permanent pacemaker. Fourteen patients (70%) experienced permanent complete right branch block, and 2 developed incomplete left anterior block and incomplete left posterior block. Six patients presented with no electrical conduction disturbance at all.

Conclusion: According to the results of the present investigation with the AV node artery derived from the right coronary artery in all cases, complete and permanent AV conduction system blockade occurred after PTSMAA in all types of anatomy regarding the observed LAD.


Alam M, Dokainish H, Lakkis N. 2006. Alcohol septal ablation for obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol 19:319-27.nChahine RA. 1991. Surgical versus medical treatment of hypertrophic cardiomyopathy: Is the perspective changing? J Am Coll Cardiol 17:643-45.nChang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. 2003. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol 42:296-300.nCoelho AA. 2008. Preditores angiográficos de alterações eletrocardiográficas após ablação septal percutânea [master's thesis]. Belo Horizonte, MG, Brazil: Fundação Cardiovascular São Francisco de Assis Verdade é Jesus; November 2008.nDidio LJA, Jatene FB. 2002. Sistema circulatório. In: Didio LJA, ed. Tratado de anatomia aplicada. São Paulo: Atheneu. p 325-35.nGuimarães JI, Nicolau JC, Pastore CA, et al. 2003. Diretriz de interpretação de eletrocardiogramade repouso. Arq Bras Cardiol 80(Suppl 2). Available at: Accessed October 29, 2009.'> C, Kurbaan A, Seggewiss U, et al. 1997. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 95:2075-81.nKuhn H, Gietzen F, Leuner C, Gerenkamp T. 1997. Induction of subaortic septal ischaemia to reduce obstruction in hypertrophic obstructive cardiomyopathy. Studies to develop a new catheter-based concept of treatment. Eur Heart J 18:846-51.nLumb G, Singletary HP. 1962. Blood supply to the atrioventricular node and bundle of His. A comparative study in pig, dog and man. Am J Pathol 41:65-79.nMarin-Neto JA, Lima Filho MO, Schmidt A, Maciel BC, Tumelero R. 1998. Cardiomiopatia hipertrófica tratada por técnica intervencionista de redução septal. Arq Bras Cardiol 70:345-50.nOsterne ECV, Seixas TN, Paulo Filho W, Osterne EM, Gomes OM. 2003. Alcoolização septal transluminal percutânea no tratamento da cardiomiopatia hipertrófica obstrutiva refratária. Experi?ncia inicial no Distrito Federal. Arq Bras Cardiol 80:359-78.nOsterne ECV, Motta VP, Motta PAM, et al. 2004. Evolução em curto e médio prazo de pacientes submetidos à ablação septal com álcool no Distrito Federal. Rev Bras Cardiol Invas 12:116-20.nQin JX, Shiota T, Lever HM, et al. 2001. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery. J Am Coll Cardiol 38:1994-2000.nRodriguez FL, Robbins SL, Banasiewicz M. 1962. The descending septal artery in human, porcine, equine, ovine, bovine and canine hearts. A postmortem angiographic study. Am Heart J 62:247-59.nRunquist LA, Nielsen CD, Killip D, Gazes P, Spencer WH 3rd. 2002. Electrocardiographic findings after alcohol septal ablation therapy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 90:1020-2.nSchlesinger MJ. 1938. An injection plus dissection study of coronary artery occlusions and anastomoses. Am Heart J 15:528-68.nSchlesinger MJ. 1948. Significant variations in the anatomic pattern on the coronary vessels. Circulation 13:61-72.nSigwart U. 1995. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 346:211-4.n



How to Cite

Gomes, O. M., Coelho, A. A., Osterne, E. C. V., & Abrantes, R. D. (2010). Coronary Morphology and Conduction System Disturbance Induced by Therapeutic Embolization of the Coronary Septal Artery. The Heart Surgery Forum, 13(1), E45-E48.